Why is Gland Pharma falling/rising?

As of 02-Jul, Gland Pharma Ltd's stock price is currently at Rs 1,866.30, reflecting a decrease of Rs 10.4 or 0.55%. The stock has underperformed its sector by 0.63% today and has experienced a trend reversal after two consecutive days of gains. It reached an intraday low of Rs 1,827, marking a decline of 2.65%. Over the past week, Gland Pharma has shown a positive return of 5.09%, and over the past month, it has increased by 15.93%. Despite this recent performance, the stock has a long-term decline of 29.73% over the past three years, contrasting sharply with the Sensex's 57.65% increase during the same period. The company benefits from a low debt-to-equity ratio and high institutional holdings at 40.18%, which may provide some stability and confidence among investors.
In the broader market context, Gland Pharma's short-term performance of 5.09% over the past week significantly outpaces the Sensex's return of 0.79% in the same timeframe. However, the stock's recent decline today suggests a potential correction after a period of gains, which could be influenced by profit-taking among investors. The increased delivery volume indicates rising investor participation, which may provide some support for the stock despite its current downturn. Overall, while Gland Pharma has shown strong short-term gains, the recent price drop reflects a combination of market dynamics and investor sentiment.